The sweet and sour of cancer: glycans as novel therapeutic targets - PubMed (original) (raw)

Review

doi: 10.1038/nrc1649.

Affiliations

Review

The sweet and sour of cancer: glycans as novel therapeutic targets

Mark M Fuster et al. Nat Rev Cancer. 2005 Jul.

Abstract

A growing body of evidence supports crucial roles for glycans at various pathophysiological steps of tumour progression. Glycans regulate tumour proliferation, invasion, haematogenous metastasis and angiogenesis, and increased understanding of these roles sets the stage for developing pharmaceutical agents that target these molecules. Such novel agents might be used alone or in combination with operative and/or chemoradiation strategies for treating cancer.

PubMed Disclaimer

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources